Efalizumab Completed Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00034203Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.